Introduction to State-of-the-Art Multidimensional Time-Resolved Spectroscopy Methods

Two-dimensional coherent electronic spectrometer with switchable multi-color configurations

Broadband implementation of two-dimensional electronic spectroscopy (2DES) is a desirable goal for numerous research groups, yet achieving it presents considerable challenges. An effective strategy to mitigate these challenges is the utilization of two-color approaches, effectively broadening the spectral bandwidth accessible with 2DES. Here, we present a simple approach to include multi-color configurations based on adjustable mirror mounts. This enables seamless toggling between single-color, two-color, and transient 2DES within the same spectroscopic apparatus, which is benchmarked on two common laser dyes, Rhodamine 6G and Nile blue. Upon mixing the dyes, single-color 2DES shows overlapping signals, whereas a high selectivity toward Nile blue responses is maintained in two-color and transient 2DES, owing to the fully resonant excitation that is spectrally shifted relative to the detection window. This method is readily implemented in other setups with similar experimental layouts and can be used as a simple solution to overcome existing bandwidth limitations. With the inclusion of transient 2DES, additional insights into excited-state processes can be gained due to its increased sensitivity toward excited-state coherences.

Two-dimensional terahertz spectroscopy of condensed-phase molecular systems

Nonlinear terahertz (THz) spectroscopy relies on the interaction of matter with few-cycle THz pulses of electric field amplitudes up to megavolts/centimeter (MV/cm). In condensed-phase molecular systems, both resonant interactions with elementary excitations at low frequencies such as intra- and intermolecular vibrations and nonresonant field-driven processes are relevant. Two-dimensional THz (2D-THz) spectroscopy is a key method for following nonequilibrium processes and dynamics of excitations to decipher the underlying interactions and molecular couplings. This article addresses the state of the art in 2D-THz spectroscopy by discussing the main concepts and illustrating them with recent results. The latter include the response of vibrational excitations in molecular crystals up to the nonperturbative regime of light-matter interaction and field-driven ionization processes and electron transport in liquid water.

Effects of high pulse intensity and chirp in two-dimensional electronic spectroscopy of an atomic vapor

The effects of high pulse intensity and chirp on two-dimensional electronic spectroscopy signals are experimentally investigated in the highly non-perturbative regime using atomic rubidium vapor as clean model system. Data analysis is performed based on higher-order Feynman diagrams and non-perturbative numerical simulations of the system response. It is shown that higher-order contributions may lead to a fundamental change of the static appearance and beating-maps of the 2D spectra and that chirped pulses enhance or suppress distinct higher-order pathways. We further give an estimate of the threshold intensity beyond which the high-intensity effects become visible for the system under consideration.

Detection of Drug Binding to a Target Protein Using EVV 2DIR Spectroscopy

We demonstrate that electron-vibration-vibration two-dimensional infrared spectroscopy (EVV 2DIR) can be used to detect the binding of a drug to a target protein-active site. The EVV 2DIR spectrum of the FGFR1 kinase target protein is found to have ∼200 detectable cross-peaks in the spectral region 1250-1750 cm^-1/2600-3400 cm^-1, with additional 63 peaks caused by the addition of a drug, SU5402. Of these 63 new peaks, it is shown that only six are due to protein-drug interactions, with the other 57 being due to vibrational coupling within the drug itself. Quantum mechanical calculations employing density functional theory are used to support assignment of the six binding-dependent peaks, with one being assigned to a known interaction between the drug and a backbone carbonyl group which forms part of the binding site. None of the 57 intramolecular coupling peaks associated with the drug molecule change substantially in either intensity or frequency when the drug binds to the target protein. This strongly suggests that the structure of the drug in the target binding site is essentially identical to that when it is not bound.